Skip to main content
Premium Trial:

Request an Annual Quote

Aussie Cancer Center Buys Whole Genome Library from Open Biosystems as Part of Open Access Program

NEW YORK, July 6 (GenomeWeb News) - Australia's Peter MacCullum Cancer Centre purchased a license to Open Biosystems' whole genome human lentiviral shRNAmir library, the company said today.

 

The transaction was made through the company's Open Access RNAi Program. The program gives the hospital access to RNAi technology, updates and upgrades, off-site backups, and a partner-specific technical support team.

 

The whole-genome resource enables the hospital's 265 investigators to target any gene in the human genome with what Open Biosystems calls improved knockdown efficiency and effectiveness.

 

Financial details were not disclosed.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.